RevoCart Taiwan blends tech and tradition at Medica 2023

_DSC0472 (1)
日期:2023-11-22
分享到:
The growing demand for cartilage regeneration in an aging society was addressed by BioGend Therapeutics.
Mr. Po-Wei Lee, the manufacturer’s Research and Development Manager, showcased their 
“RevoCart” system, an autologous transplantation solution that regenerates durable, hyaline-like cartilage.
Using finely-ground cartilage from the non-weight-bearing side of a patient’s joint, the material is enriched using a special enzyme and implanted into the damaged cartilage with a bioresorbable scaffold (chondroplug) – a procedure with proven long-time success in clinical trials.


NEWS